Deutsche Bank
http://www.db.com/
Deutsche Bank is a leading global investment bank with a strong and profitable private clients franchise.
The company operates through three divisions: Corporate and Investment Bank (CIB), Private Clients and Asset Management (PCAM) and Corporate Investments (CI) . The CIB division engages in the origination, sale, financing, structuring, and trading of fixed income, equity, equity-linked, convertible bond, foreign exchange, and commodities products. The PCAM segment provides portfolio/fund management products, including active fund management, passive/quantitative fund management, alternative investments, and discretionary portfolio management solutions in Germany and other continental European countries.-
Dendreon to Host Conference Call on May 9 to Announce First Quarter Financial Results
-
Unusual 11 Mid-Day Movers 07/31: (AH) (INOD) (AVID) Higher; (PRSS) (RLD) (DNDN) Lower
-
Notable Analyst Rating Changes 07/31: (HCBK) (NSPH) (HOLX) Upgraded; (DNDN) (CBI) (COH) Downgraded
-
Deutsche Bank Downgrades Dendreon (DNDN) to Hold; Sidelined as Gap in Sales Force to Delay Provenge Growth
-
Notable Analyst Rating Changes 07/30: (DNDN) (PSX) (CHS) Upgraded; (JPM) (LLY) (EQIX) Downgraded
-
Streetinsider.com's Hot Lunchtime Reads 06/04: (AAPL) (DNDN) (MSFT) (FB) (RIMM)
-
Deutsche Bank Defends Dendreon (DNDN) Despite Strong Zytiga Data; Maintains Buy
-
Notable Analyst Rating Changes 05/23: (SBUX) (AMAT) (WMB) Upgraded; (NDAQ) (PSO) (ARBA) Downgraded
-
Dendreon (DNDN) Hit On Various Worries, Deutsche Bank Defends
-
Deutsche Bank Maintains a 'Buy' on Dendreon (DNDN): Buyers on Any Weakness
-
Deutsche Bank Says Dendreon (DNDN) CEO Departure a "Surprise," But New CEO Brings M&A History
-
Wall Street Mostly Positive On Today's Dendreon (DNDN) News, But Mixed Over Near-Term
-
Early 2012 Uptick Expected for Dendreon's (DNDN) Provenge
-
Notable Analyst Rating Changes 09/16: (EBAY) (LYG) (REV) Upgraded; (RIMM) (ADBE) (SSYS) Downgraded
-
Pre-Open Movers 9/12: (GLBL) (NETL) (MHP) Higher; (VSH) (DB) (BAC) Lower
-
Notable Analyst Rating Changes 05/23: (GPS) (AKS) (LTD) Upgraded; (LDK) (ERIC) (ONNN) Downgraded
-
Deutsche Bank Reiterates a 'Buy' on Dendreon (DNDN); CMS Less Restrictive on Off-Label Use
-
Deutsche Bank Raises Price Target On Dendreon (DNDN) to $54
-
Analysts Remain Bullish on Dendreon (DNDN) Following Positive MEDCAC Review
-
Dendreon (DNDN) Halted Pending CMS MEDCAC Meeting
-
Deutsche Bank Starts Dendreon (DNDN) at Buy, $44 Price Target
-
Notable Analyst Rating Changes 1/7: BAC, SHLD, THC, IT, ZUMZ, CITP Upgraded; RAI, AA, RAD, WEN, BEXP Downgraded
-
Dendreon (DNDN) Prices 15M Common Offering at $24.75/Share
-
After-Hours Movers 12/08: EFJI, DPS, CMTL, AVAV Higher; MW, NCS, CKR, AINV, SAI, TXN Lower
-
Dendreon (DNDN) Announces 15M Share Offering
-
Deutsche Bank Said FDA Guidance Documents Support Dendreon's (DNDN) Provenge Approval
-
Notable Analyst Rating Changes 6/10: YHOO, X, ZEUS, DB Upgraded; SINA, CRDN, FSLR, PLL Downgraded
-
Notable Analyst Rating Changes 6/5: TIN, NKE, PHM, JTX Upgraded; GPS, ANF, HOG, DD Downgraded
-
Deutsche Bank Starts Dendreon (DNDN) At Buy, Says Provenge Will Be a "Blockbuster"
-
Dendreon (DNDN) Announces Closing of 10.7M Share Stock Offering
-
Dendreon (DNDN) Prices 10.7M Share Offering at $19.20
-
Morning Movers 4/20: JAVA, PAS, ABTL, PBG, NVGN Higher; DSCO, DISK, VSNT, NTLS, MMR Lower
-
Morning Movers 4/15: PJC, SYT, GM, IP, CSX Higher; GRRF, CYNO, RJF, BKC, FSC, BTU, SKYW Lower
-
Morning Movers 4/14: DNDN, DBRN, AIG, MGM, FSS, LVS Higher; TLB, SXL, MS, VCLK, OESX, PTRY Lower
-
Morning Movers 4/6: SUMT, LGCY, MGM, DNDN, IFX, SLTC Higher; JAVA, AXA, SONC, AVCT Lower
